[
  {
    "ts": null,
    "headline": "Apple, Amgen share losses lead Dow's 175-point drop",
    "summary": "Apple, Amgen share losses lead Dow's 175-point drop",
    "url": "https://finnhub.io/api/news?id=7e25b1270deb7026de6b6b34b197b6c67acfb06bf1c29aaf9f0189d9baa3ae69",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740582780,
      "headline": "Apple, Amgen share losses lead Dow's 175-point drop",
      "id": 132881137,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Apple, Amgen share losses lead Dow's 175-point drop",
      "url": "https://finnhub.io/api/news?id=7e25b1270deb7026de6b6b34b197b6c67acfb06bf1c29aaf9f0189d9baa3ae69"
    }
  },
  {
    "ts": null,
    "headline": "Boeing, Apple share losses lead Dow's 289-point drop",
    "summary": "Boeing, Apple share losses lead Dow's 289-point drop",
    "url": "https://finnhub.io/api/news?id=8d5e76ddd9b6246d79b92079eb11f2b417b104f10a3350efd56591f7449c19b4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740578220,
      "headline": "Boeing, Apple share losses lead Dow's 289-point drop",
      "id": 132881138,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Boeing, Apple share losses lead Dow's 289-point drop",
      "url": "https://finnhub.io/api/news?id=8d5e76ddd9b6246d79b92079eb11f2b417b104f10a3350efd56591f7449c19b4"
    }
  },
  {
    "ts": null,
    "headline": "Dow falls 110 points on losses for Boeing, Amgen shares",
    "summary": "Dow falls 110 points on losses for Boeing, Amgen shares",
    "url": "https://finnhub.io/api/news?id=0c818dab1edd19660f0d68c466c099a114115cbcf0d50af0a1123c1a58cc8252",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740574560,
      "headline": "Dow falls 110 points on losses for Boeing, Amgen shares",
      "id": 132881139,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Dow falls 110 points on losses for Boeing, Amgen shares",
      "url": "https://finnhub.io/api/news?id=0c818dab1edd19660f0d68c466c099a114115cbcf0d50af0a1123c1a58cc8252"
    }
  },
  {
    "ts": null,
    "headline": "Merck's Oncology Strength: Beating Wall Street Again",
    "summary": "Merck's Q4 2024 results surpassed expectations, driven by strong oncology sales and growth in Keytruda. See why I think MRK may work for income investors.",
    "url": "https://finnhub.io/api/news?id=48cc045b6210dbf5fc551d979a18cc216581d878f6df5c6d273d0c4b6879a62b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740561344,
      "headline": "Merck's Oncology Strength: Beating Wall Street Again",
      "id": 132878313,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/151810706/image_151810706.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Merck's Q4 2024 results surpassed expectations, driven by strong oncology sales and growth in Keytruda. See why I think MRK may work for income investors.",
      "url": "https://finnhub.io/api/news?id=48cc045b6210dbf5fc551d979a18cc216581d878f6df5c6d273d0c4b6879a62b"
    }
  },
  {
    "ts": null,
    "headline": "Miller-Howard Income-Equity Q4 2024 Commentary",
    "summary": "Both versions of Miller-Howard Income-Equity outperformed the Russell 1000 Value Index for the fourth quarter and for 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=2b3602619dd9439e98f6576dac3d46b062c9d1a5dae95b3aaee3c4a3c5d4f012",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740548700,
      "headline": "Miller-Howard Income-Equity Q4 2024 Commentary",
      "id": 132877054,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2167331445/image_2167331445.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Both versions of Miller-Howard Income-Equity outperformed the Russell 1000 Value Index for the fourth quarter and for 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=2b3602619dd9439e98f6576dac3d46b062c9d1a5dae95b3aaee3c4a3c5d4f012"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co.'s Real Value: A Deep Dive Into Its Fundamentals",
    "summary": "While Merck reported strong financial results in recent quarters, it faces both upsides and risks in the future. Read why I'm neutral on MRK stock.",
    "url": "https://finnhub.io/api/news?id=8028264f40c3eac75912d2fb3b7f2f4ad4ed59948b1b57fc49f31d955e040172",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740548470,
      "headline": "Merck & Co.'s Real Value: A Deep Dive Into Its Fundamentals",
      "id": 132876996,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2113989619/image_2113989619.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "While Merck reported strong financial results in recent quarters, it faces both upsides and risks in the future. Read why I'm neutral on MRK stock.",
      "url": "https://finnhub.io/api/news?id=8028264f40c3eac75912d2fb3b7f2f4ad4ed59948b1b57fc49f31d955e040172"
    }
  }
]